Park Ha Biological Tech-A
13F holders, Q1 2025 (March 31)4holders
2new positions
2sold out
1famous investor
$13.21avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Park Ha Biological Tech-A in their 13F filings, unchanged from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($222K), Citadel Advisors ($220K) and HRT Financial LP ($195K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Park Ha Biological Tech-A
- CUSIP
- G6925R102
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $252K |
| Exits | 2 | $181K |
All 13F filers, Q4 2024 → Q1 2025: 19,047 shares bought and 48,520 shares sold, net −29,473 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Geode Capital Management, LLC | 0.00% | New | 16,785 | $222K |
| Citadel Advisors | 0.00% | Reduce -44.2% | 16,606 | $220K |
| HRT Financial LP | 0.00% | Reduce -31.0% | 14,787 | $195K |
| Royal Bank of Canada | 0.00% | New | 2,262 | $30K |
"% of holder's portfolio" is PARK HA BIOLOGICAL TECH-A's weight in each manager's 13F, not the share of Park Ha Biological Tech-A the manager owns.